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Inaugural issue of Stem Cell ResearchDo not fear going forward slowly; fear only to stand still.
One generation plants the trees; another gets the shade.
—Chinese proverbs
Stem cells have captivated the imagination, hopes and
dreams of the world. Whilst heated debate will continue over
the ethics, attributes and potentials of embryonic versus
adult stem cells, one thing is sure—millions are watching,
either as hopeful beneficiaries of a new therapy or just
engrossed in the whole phenomenon.
It is auspicious that the breaking news, as this editorial
was going to press, was the announcement from the
Karolinska Institute in Stockholm that the 2007 Nobel Prize
in Physiology or Medicine was shared by Mario Capecchi,
Martin Evans and Oliver Smithies “for their discoveries of
principles for introducing specific gene modifications in mice
by the use of embryonic stem cells”.
Just type the words “stem cells” into the Google™ search
engine, or “stem cell therapy”, or “regenerative medicine”
and you will be rewarded with literally millions of hits to
browse through. Thus is the intense interest in stem cell
technologies that has gripped the world—everyone is thirst-
ing for information. (You want “information on stem cells”—
there are over 7 million hits clamouring for top spot!)
The science of stem cell research has also gathered
momentum, but more gradually. Searching the PubMed
service of the US National Library of Medicine for “stem
cells” yields over 11,000 articles for the 2006 calendar year,
double the number in 1993 and four times as many articles as
in 1980. Not surprisingly, the most rapid recent increase has
been in embryonic stem cell related papers. Since the initial
derivation of mouse embryonic stem cells by Martin Evans
and Matthew Kaufman (Evans and Kaufman, 1981) and Gail
Martin (Martin, 1981), there was a modest yearly increment
in embryonic stem cell related publications until 1998, when
the seminal reports of the first human embryonic stem cell
and germ cell lines appeared from the laboratories of James
Thomson (Thomson et al., 1998) and John Gearhart
respectively (Shamblott et al., 1998). In the 6–8 years
since these discoveries, the number of embryonic stem cell
related publications has risen nearly 10-fold—from 140 in
1997 to over 1100 in 2006.1873-5061/$ – see front matter © 2007 Published by Elsevier B.V.
doi:10.1016/j.scr.2007.10.001But where did stem cell research begin? Arguably, it began
with the bone marrow and hematopoiesis. There is now 50
years of literature replete with the accomplishments of trail
blazers such as Nobel Prize winner E. Donnall Thomas in bone
marrow transplantation and Lasker Award winners Donald
Metcalf and James Till and Ernest McCulloch, who made huge
contributions to the science of hematopoiesis and stem cells,
to name but a very few.
In his historical review of hematopoietic cell transplanta-
tion, Thomas (1999) recalls the first attempts to treat human
patients suffering from leukemia with total body irradiation
or chemotherapy and a bone marrow infusion in 1957. The
only early successes were in cases in which transplants
utilized bone marrow from an identical twin donor—indeed,
when reviewed in 1970 all allogeneic transplants to that date
had failed. It was not until the recognition of the importance
of human leukocyte antigen (HLA) matching that successful
allogeneic bone marrow transplantation was reported. In
1977, Thomas’s Seattle group reported the long-term
survival of 17 of 100 leukemic patients treated with bone
marrow from an HLA-matched sibling. The last 30 years has
seen further refinements in all aspects of this basic
therapeutic technique. For example, we now understand
enough about the biology and characteristics of hemato-
poietic stem cells to isolate enriched populations from bone
marrow and peripheral blood. In recent decades umbilical
cord blood has been recognized as a rich and valuable source
of hematopoietic (and other) stem cells. Immunosuppressive
regimens have become more sophisticated, working towards
a balance between graft tolerance, immunological recovery
and a positive anti-leukemic effect of the graft.
These clinical studies, however, did not take place in a
vacuum. In parallel, basic aspects of blood cell biology were
being teased out by Till and McCulloch (McCulloch and Till,
2005), who, in 1961, observed that rare primitive murine
bone marrow cells had the ability to form macroscopic
colonies in the spleens of irradiated mice—cells that they
dubbed ‘spleen colony forming cells’, or CFU-S. These
studies led them to propose two of the defining properties
of stem cells in 1963—self-renewal, the ability to give rise to
new stem cells, and differentiation, the ability of stem cells
to give rise to many progeny with the characteristics of
mature blood cells. On the other side of the Earth, Ray
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vitro culture techniques for the visualization and enumera-
tion of hematopoietic progenitor cells. Elucidation, purifica-
tion, identification and clinical application of the growth
factors stimulating these hematopoietic progenitor cells
have occupied Metcalf for the past 40 years (Metcalf, 2000).
Why have I digressed to outline these events? I believe
these studies illustrate paradigms that are relevant to stem
cell research today. First, we can see that clinical and
scientific research proceed hand in hand, in a complemen-
tary manner. Second, there was a requirement for a dogged
persistence that led to success in the vignettes that I have
presented. These studies all spanned decades. Third,
combined progress in this field has been the sum of an
international, global effort involving scientists and clinicians
from all around the world. Finally, it is not over yet. Despite
50 years of research there remain many and significant
unsolved problems, not the least of which is that we are still
unable to expand repopulating hematopoietic stem cells in
vitro.
So, how will Stem Cell Research fit into the modern day
landscape? With the ongoing increase in research in the field
of stem cells, I believe that a niche exists for a journal
dedicated to publishing high-quality, peer-reviewed
research articles focusing on the biology and applications
of stem cell research. We have endeavoured to establish
Stem Cell Research as a global journal—between myself
(Melbourne, Australia) and the Associate Editors Professor
Christine Mummery (Utrecht, The Netherlands), Professor
Paul Simmons (Houston, Texas, USA) and Professor Markus
Grompe (Portland, Oregon, USA) we span Europe, America
and the Asia Pacific. Worldwide support for our initiative isevidenced by the expanding, prestigious scientific editorial
board that supports us.
We will make every effort to handle submissions swiftly
and fairly and provide rapid reviews, taking advantage of the
sophisticated electronic infrastructure and facilities pro-
vided by Elsevier. Our aim is to form an integral part of the
international network of communication of science that
drives stem cell research now and in the future.
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